Dublin, Jan. 29, 2024 (GLOBE NEWSWIRE) -- The "TC-210 Emerging Drug Insight and Market Forecast - 2032" report has been added to ResearchAndMarkets.com's offering. The clinical landscape of malignant ...
- TCR2 to host conference call today starting at 8:00am E.T. with live webcast available online “We are delighted that our very first dose of TC-210 induced consistent tumor regression and clinical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback